Literature DB >> 21320056

Discovery of modulators of protein-protein interactions: current approaches and limitations.

Lidio M C Meireles1, Gabriela Mustata.   

Abstract

Protein-protein interactions are involved in most of the essential processes that occur in living organisms from cell motility to DNA replication, which makes them interesting targets for drug discovery. However, due to the lack of deep pockets, and the large contact surfaces involved in these interactions, they are considered challenging targets and have been often times dismissed as "undruggable". Nonetheless, significant efforts in pharmaceutical and academic laboratories have been devoted to finding ways to exploit protein-protein interactions as drug targets. This article provides an overview of the principles underlying the main general strategies for discovering small-molecule modulators of protein-protein interactions, namely: high-throughput screening, fragment-based drug discovery, peptide-based drug discovery, protein secondary structure mimetics, and computer-aided drug discovery. In addition, examples of successful discovery of modulators of protein-protein interactions are discussed for each of those strategies.

Mesh:

Substances:

Year:  2011        PMID: 21320056     DOI: 10.2174/156802611794072632

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  32 in total

1.  Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.

Authors:  Robert A Mook; Jiangbo Wang; Xiu-Rong Ren; Minyong Chen; Ivan Spasojevic; Larry S Barak; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem       Date:  2015-08-10       Impact factor: 3.641

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

3.  Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.

Authors:  Medhanit Bahta; Fa Liu; Sung-Eun Kim; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

4.  Exploring key orientations at protein-protein interfaces with small molecule probes.

Authors:  Eunhwa Ko; Arjun Raghuraman; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2012-12-27       Impact factor: 15.419

5.  Protein interface remodeling in a chemically induced protein dimer.

Authors:  Brian R White; Jonathan C T Carlson; Jessie L Kerns; Carston R Wagner
Journal:  J Mol Recognit       Date:  2012-07       Impact factor: 2.137

6.  Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

Authors:  Da Duan; Hayarpi Torosyan; Daniel Elnatan; Christopher K McLaughlin; Jennifer Logie; Molly S Shoichet; David A Agard; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2016-12-16       Impact factor: 5.100

7.  Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.

Authors:  Daniel W Carney; John C Lukesh; Daniel M Brody; Manuela M Brütsch; Dale L Boger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-10       Impact factor: 11.205

8.  Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth.

Authors:  Jayanta Bhattacharyya; Xiu-Rong Ren; Robert A Mook; Jiangbo Wang; Ivan Spasojevic; Richard T Premont; Xinghai Li; Ashutosh Chilkoti; Wei Chen
Journal:  Nanoscale       Date:  2017-08-31       Impact factor: 7.790

9.  Small molecule modulators of Wnt/β-catenin signaling.

Authors:  Robert A Mook; Minyong Chen; Jiuyi Lu; Larry S Barak; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

10.  Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.

Authors:  Wenjian Qian; Jung-Eun Park; Fa Liu; Kyung S Lee; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2012-05-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.